#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteosarcoma metastatic Neoplasm Marginal zone lymphoma refractory Myxoid liposarcoma Central nervous system neoplasm Still's disease Hodgkin's disease Glioma Infantile spasms Fatty acid oxidation disorder Heritable pulmonary arterial hypertension Blood iron increased Chronic graft versus host disease in intestine Immune-mediated enterocolitis Small for dates baby More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma – Basic Information Paroxysmal nocturnal haemoglobinuria – Basic Information Skin angiosarcoma – Trials in Disease Amyotrophic lateral sclerosis – Trials in Disease Haemophilia B without inhibitors – Trials in Disease Mantle cell lymphoma – Treatment IgA nephropathy – Life with Disease Osteosarcoma metastatic – Basic Information Medulloblastoma – Diagnostics Mantle cell lymphoma stage II – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cetrorelix Daunorubicin MB-HUCART19.1 Sacubitril Valsartan Isoniazid Vanglusagene Ensiparvovec Elranatamab Mavacamten Vortioxetine Hydrobromide Venlafaxine Hydrochloride INCB123667 Glatiramer Acetate Lufepirsen ANTI-GD2-800CW Zongertinib Tarlatamab ADCE-D01 Azelastine Human Coagulation Factor Viii Db-1303 More therapies…

    Learn about Your Condition

    Growth hormone deficiency Diverticulitis Shock Petit mal epilepsy Endometrial cancer stage I Osteonecrosis of jaw Dermatomyositis Migraine without aura Hypopituitarism Bronchiectasis Scoliosis Hypogonadism male Hepatic cirrhosis Pertussis Langerhans cell sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of B Cell Response to Tetanus Toxoid Vaccination in Patients with Systemic Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Systemic lupus erythematosus
    • Systemic scleroderma
    Investigated Drugs:
    • TETANUS TOXOID
    The Netherlands

  • Safety and imaging quality study of perflutren contrast agent (HarMono-T) during kidney ultrasound in healthy volunteers

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Perflutren
    Germany

  • Safety and efficacy study of nadofaragene firadenovec administered to the renal pelvis in adults with low-grade upper tract urothelial carcinoma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • NADOFARAGENE FIRADENOVEC
    France The Netherlands Spain

  • Comparison of compression therapy alone versus compression therapy with phenoxymethylpenicillin for preventing recurrent erysipelas in lower limbs

    Not yet recruiting

    3 1 1 1
    France

  • Study comparing CHF 5993 (beclometasone/formoterol/glycopyrronium) to fluticasone/salmeterol inhalation in adolescents with uncontrolled asthma on medium-dose inhaled therapy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Salmeterol
    • Fluticasone Propionate
    Germany Italy Spain

  • Study of bedaquiline, pretomanid, linezolid and moxifloxacin combination treatment for patients with multidrug-resistant tuberculosis in France

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Bedaquiline
    • Clofazimine
    • Moxifloxacin
    France
Previous Page
1 … 768 769 770 771 772 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!